Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00825292 · ClinicalTrials.gov registry record · Phase 2
Detection and Classification of Colon Polyps
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00825292: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00825292 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00825292, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
Colon cancer is the third most common cancer in western society. To prevent colon cancer it is recommended for people to undergo a screening colonoscopy at the age of fifty. The purpose of the colonoscopy is to remove polyps, since some of these lesions are precancerous. Precancerous polyps are called adenomas. This method of prevention is effective, but the standard colonoscopy currently used does not detect all polyps. Studies have reported a polyp miss rate of about 24%. Furthermore, we are unable to distinguish precancerous polyps from benign polyps, also known as hyperplastic polyps, with standard colonoscopy. This results in all polyps being removed at time of colonoscopy, even the benign polyps. To help improve the detection of colon polyps new endoscopic technologies have been developed. These technologies include high definition white light (HDWL)and high definition narrow band imaging (HDNBI). HDWL improves the overall resolution of the images seen during colonoscopy. HDNBI can help us better classify polyps by enhancing their tissue appearance as well as seeing small blood vessels and capillaries. The goal of this study to determine if HDNBI imaging shows an increased polyp detection rate when compared to the current standard colonoscopy. In addition to develop a classification system to help better differentiate between precancerous polyps and their benign counterparts using HDWL and HDNBI.
Interventions
- PROCEDURE Polp removal and identification
- PROCEDURE colon polyp removal
- PROCEDURE ETMI colonoscope (ETMI scope is a FDA approved device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00825292
The ClinicalTrials.gov registry entry for NCT00825292 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Polp removal and identification is the first listed.
NCT00825292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00825292 about?
NCT00825292 is a clinical study titled "Detection and Classification of Colon Polyps". Colon cancer is the third most common cancer in western society. To prevent colon cancer it is recommended for people to undergo a screening colonoscopy at the age of fifty. The purpose of the colonoscopy is to remove polyps, since some of these lesions are precancerous. Precancerous polyps are call...
What is the current status of trial NCT00825292?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2006-07. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00825292?
The interventions under investigation include: Polp removal and identification (PROCEDURE), colon polyp removal (PROCEDURE), ETMI colonoscope (ETMI scope is a FDA approved device) (PROCEDURE).
Who is sponsoring clinical trial NCT00825292?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.